• PureTech’s Founded Entity Gallop Oncology Announces Positive Initial Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

  December 9, 2025 4:40 am

• Dosbai Saparov: Three-Year Hematology and Medical Oncology Training at OBH–Brookdale Hospital

  December 9, 2025 4:20 am

• NCCN Guidelines in nccRCC Weigh New Data for Combinations

  December 9, 2025 4:16 am

• ASTRO–BCRF Emerging Investigator Award

  December 9, 2025 4:11 am

• Kura Oncology and Kyowa Kirin Report Combination Data for

  December 8, 2025 1:47 pm

• PureTech’s Founded Entity Gallop Oncology Announces Positive Initial Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

  December 8, 2025 12:13 pm

• GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck Cancer

  December 8, 2025 12:09 pm

• HMA/Venetoclax Ups EFS, QOL in Patients With Acute Myeloid Leukemia

  December 8, 2025 11:30 am

• 10 Must-Read Posts in GI Oncology This Week

  December 8, 2025 11:26 am

• 10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team

  December 8, 2025 11:05 am